Flat ₹100 OFF on First app order | Use Code: APP100 |
Flat ₹100 OFF
on First app order
Use Code
APP100
Download Now
100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Salt Composition in bothNitrofurantoin 100mg
Niftanik 100mg Tablet SR 10s
You Searched
Niftanik 100mg Tablet SR 10s
Amagen India Life Sciences
₹150
Our Recommendation
Uriron 100mg Tablet SR 14s
754+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
Used In
Treatment of Bacterial infections of urinary tract
Customers also bought
More About Niftanik
Benefits
In Treatment of Bacterial infections of urinary tract : Niftanik 100mg Tablet SR works by stopping the growth of the bacteria in the urine that cause urinary tract infections. This medicine usually makes you feel better quite quickly. However, you should continue taking it as long as it is prescribed even when you feel better, to make sure that all bacteria are killed and do not become resistant.
Side Effects
Side effects of Niftanik Tablet SRThe majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Niftanik Nausea Vomiting Diarrhea
How to use
How to use Niftanik Tablet SRFollow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Niftanik 100mg Tablet SR is to be taken with food.
How it works
How Niftanik Tablet SR works Niftanik 100mg Tablet SR is an antibiotic. It works by killing the bacteria in the urine that causes infection.
Unsafe: It is unsafe to consume alcohol while taking Niftanik 100mg Tablet SR , as it may lead to symptoms such as flushing, increased heart rate, nausea, thirst, chest pain, and low blood pressure, known as a Disulfiram reaction.
Niftanik 100mg Tablet SR is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Niftanik 100mg Tablet SR should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Niftanik 100mg Tablet SR may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Niftanik 100mg Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Niftanik 100mg Tablet SR may be needed. Doctor consultation is advised.Use of Niftanik 100mg Tablet SR is not recommended in patients with severe kidney disease, who are unable to pass urine or have high creatinine levels.
Niftanik 100mg Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Niftanik 100mg Tablet SR may be needed. Doctor consultation is advised.Use of Niftanik 100mg Tablet SR is not recommended in patients with severe liver disease and active liver disease.
What if I forget to take it?
If a dose of Niftanik 100mg Tablet SR is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
House No. 24 Pocket B-4 Sector 8 Rohini, Rohini Sector 8, Jammu-110085, Jammu & Kashmir, India
References
Petri WA Jr. Sulfonamides, Trimethoprim-Sulfamethoxazole, Quinolones, and Agents for Urinary Tract Infections. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1474-75
Chambers HF, Deck DH. Miscellaneous Antimicrobial Agents; Disingectants, Antiseptics, & Sterilants. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 878
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 984-86
Nitrofurantoin. North Norwich, New York: Norwich Pharmaceuticals, Inc.; 2008 (28 Mar. 2019)
Central Drugs Standard Control Organisation (CDSCO) (28 Mar. 2019)
Nitrofurantoin monohydrate/macrocrystals (06 Apr. 2023)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
